Tech Company Financing Transactions
Generare Funding Round
Alven Capital Partners, Daphni and Galion.exe joined a $23 million Series A capital raise for Generare. The round was announced on 4/2/2026.
Transaction Overview
Company Name
Announced On
4/2/2026
Transaction Type
Venture Equity
Amount
$23,000,000
Round
Series A
Investors
Alven Capital Partners (Lead Investor)
Daphni (Lead Investor)
Proceeds Purpose
The funding will be used to expand the company's compound library, scale its discovery platform, and grow its multidisciplinary team as it continues to develop its data-driven approach to drug discovery.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
4 Rue Maillard
Paris, 75011
France
Paris, 75011
France
Phone
Undisclosed
Website
Email Address
Overview
Generare is unlocking nature's untapped potential, translating the complexity of microbial DNA into a scalable platform that can transform drug discovery. By leveraging cutting-edge biotechnology and data, we are accelerating the identification of new bioactive molecules, for medicine and beyond.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Guillaume Vandenesch
Chief Scientific Officer
Vincent Libis
Browse more venture capital transactions:
Prev: 4/2/2026: Pickmybrain venture capital transaction
Next: 4/2/2026: Covalo venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs